Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3
Titel:
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3
Auteur:
Cristofanilli, Massimo DeMichele, Angela Giorgetti, Carla Turner, Nicholas C. Slamon, Dennis J. Im, Seock-Ah Masuda, Norikazu Verma, Shailendra Loi, Sherene Colleoni, Marco Theall, Kathy Puyana Huang, Xin Liu, Yuan Bartlett, Cynthia Huang